Advertisement

Neuromuscular Blocking Activity

  • Hans-Peter Hartung
Living reference work entry

Abstract

Neuromuscular transmission is mediated by nicotinic acetylcholine receptors for which various subtypes are described (Sargent 1993; McGehee and Role 1995; Karlin and Akabas 1995; Alexander et al. 2001).

Keywords

Sciatic Nerve Neuromuscular Blockade Neuromuscular Blocking Neuromuscular Transmission Nictitate Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Further Reading

General Considerations

  1. Alexander S, Peters J, Mathie A, MacKenzie G, Smith A (2001) TiPS nomenclature supplement 2001Google Scholar
  2. Allmark MG, Bachinski WM (1949) A method of assay for curare using rats. J Am Pharm Assoc 38:43–45CrossRefGoogle Scholar
  3. Burn JH, Finney DJ, Goodwin LG (1952) Biological standardization. Chapter XX, Curare-like compounds. Oxford University Press, London/New York/Toronto, pp 345–354Google Scholar
  4. Collier HOJ, Hall RA, Fieller EC (1949) Use of a rotating drum in assessing the activities of paralysant, convulsant and anaesthetic drugs. Analyst 74:592–596CrossRefPubMedGoogle Scholar
  5. Fatt P, Katz B (1951) An analysis of the end-plate potential recorded with an intra-cellular electrode. J Physiol 115:320–370CrossRefPubMedCentralPubMedGoogle Scholar
  6. Hoppe JO (1955) Observations on the potency of neuromuscular blocking agents with particular reference to succinylcholine. Anesthesiology 16:91–124Google Scholar
  7. Hunter JM (1995) New neuromuscular blocking drugs. N Engl J Med 332:1691–1699CrossRefPubMedGoogle Scholar
  8. Karlin A, Akabas MH (1995) Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15:1231–1244CrossRefPubMedGoogle Scholar
  9. Levis S, Preat S, Dauby J (1953) Étude pharmacodynamique de deux séries de curarisants de synthèse. Arch Int Pharmacodyn Ther 93:46–54Google Scholar
  10. McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521–546CrossRefPubMedGoogle Scholar
  11. Prior C, Dempster J, Marshall IG (1993) Electrophysiological analysis of transmission at the skeletal neuromuscular junction. J Pharmacol Toxicol Methods 30:1–17CrossRefPubMedGoogle Scholar
  12. Sargent PB (1995) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403–443CrossRefGoogle Scholar
  13. Savarese JJ, Antonio RP, Ginsburg S (1975) Potential uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments. Anesth Analg 54:669–678CrossRefPubMedGoogle Scholar
  14. Skinner HG, Young DM (1947) A mouse assay for curare. J Pharmacol Exp Ther 91:144–146PubMedGoogle Scholar
  15. Varney RF, Linegar CR, Holaday HA (1948) The rabbit ‘head-drop’ method for the biological assay of curare and its alkaloids. Fed Proc 7:261–262PubMedGoogle Scholar
  16. Varney RF, Linegar CR, Holaday HA (1949) The assay of curare by the rabbit ‘head-drop’ method. J Pharmacol Exp Ther 97:72–83PubMedGoogle Scholar
  17. Zaimis E, Head S (1976) Depolarizing neuromuscular blocking drugs. In: Zaimis E (ed) Neuromuscular junction. Handbook of experimental pharmacology, vol 42. Springer, Berlin/Heidelberg/New York, pp 365–419CrossRefGoogle Scholar

Isolated Phrenic Nerve Diaphragm Preparation of the Rat

  1. Beani L, Bianchi C, Ledda F (1964) The effect of tubocurarine on acetylcholine release from motor nerve terminals. J Physiol 174:172–183CrossRefPubMedCentralPubMedGoogle Scholar
  2. Birmingham AT, Hussain SZ (1980) A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants. Br J Pharmacol 70:501–506CrossRefPubMedCentralPubMedGoogle Scholar
  3. Bülbring E (1946) Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol 1:38–61Google Scholar
  4. Bülbring E, Chou TC (1947) The relative activity of prostigmine homologues and other substances as antagonists to tubocurarine. Br J Pharmacol 2:8–22Google Scholar
  5. Chang CC, Chuang ST, Lee CY, Weio JW (1972) Role of cardiotoxin and phospholipase A in the blockade of nerve conduction and depolarization of skeletal muscle induced by cobra venom. Br J Pharmacol 44:752–764CrossRefPubMedCentralPubMedGoogle Scholar
  6. Colbert WE, Wilson BF, Williams PD (1990) The effects of temperature on the experimental reliability of the isolated rat phrenic nerve/diaphragm preparation. J Pharmacol Meth 24:53–57CrossRefGoogle Scholar
  7. Hoppe JO (1955) Observations on the potency of neuromuscular blocking agents with particular reference to succinylcholine. Anesthesiology 16:91–124Google Scholar
  8. Jenden DJ (1955) The effect of drugs upon neuromuscular transmission in the isolated guinea pig diaphragm. J Pharmacol Exp Ther 114:398–408PubMedGoogle Scholar
  9. Jenden DJ, Kamijo K, Taylor DB (1994) The action of decamethonium on the isolated rabbit lumbrical muscle. J Pharmacol Exp Ther 111:229–240Google Scholar
  10. Kojima M, Takagi H (1969) Effects of some anticholinergic drugs on antidromic activity in the rat phrenic nerve-diaphragm preparation. Eur J Pharmacol 5:161–167CrossRefPubMedGoogle Scholar
  11. Long JP, Chiou CY (1970) Pharmacological testing methods for drugs acting on the peripheral nervous system. J Pharm Sci 59:133–148CrossRefPubMedGoogle Scholar
  12. Muarata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H, Fukatsu Y, Isogaya M, Yamada N, Nishio S (1989) General pharmacology of beraprost sodium. 2nd communication: effects on the autonomic, cardiovascular and gastrointestinal systems, and other effects. Arzneimittelforschung 39:867–876Google Scholar
  13. Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG (1989) Effects of a new neuromuscular blocking agent (ORG 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 63:400–410Google Scholar
  14. Randic M, Straughan DM (1964) Antidromic activity in the rat phrenic nerve-diaphragm preparation. J Physiol 173:130–148CrossRefPubMedCentralPubMedGoogle Scholar
  15. Thesleff S (1958) A study on the interaction between neuromuscular blocking agents and acetylcholine at the mammalian motor end-plate. Acta Anaesthesiol Scand 2:69–79CrossRefPubMedGoogle Scholar
  16. Van Riezen H (1968a) Classification of neuromuscular blocking agents in a new neuromuscular preparation of the chick in vitro. Eur J Pharmacol 5:29–36CrossRefPubMedGoogle Scholar
  17. Van Riezen H (1968b) Effect of cholinergic and anticholinergic drugs on a new neuromuscular preparation of the chick. Eur J Pharmacol 5:37–48CrossRefPubMedGoogle Scholar
  18. Vizi ES, Tuba Z, Maho S, Foldes FF, Nagano O, Doda M, Takagi S, Chaudhry IA, Saubermann AJ, Nagashima H (2003) A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side effects. Acta Anaesthesiol Scand 47:291–300CrossRefPubMedGoogle Scholar
  19. Wessler I, Kilbinger H (1986) Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol 334:357–364CrossRefPubMedGoogle Scholar
  20. Wessler I, Steinlein O (1987) Differential release of [3H]acetylcholine from the rat phrenic nerve-hemidiaphragm preparation by electrical nerve stimulation and by high potassium. Neuroscience 22:289–299CrossRefPubMedGoogle Scholar
  21. Wessler I, Wagner G, Walczok A (1992) Suppression by cholinesterase inhibition of a Ca2+-independent efflux of [3H]acetylcholine from the neuromuscular junction of the isolated rat diaphragm. Eur J Pharmacol 221:371–376CrossRefPubMedGoogle Scholar
  22. West GB (1947) Note on the biological assay of tubocurarine. Q J Pharm Pharmacol 20:518–527PubMedGoogle Scholar

Sciatic Nerve-Gastrocnemius Muscle Preparation in the Rabbit

  1. Benz FW, Long JP (1969) Investigations on a series of heterocyclic hemicholinium-3 analogs. J Pharmacol Exp Ther 166:225–236PubMedGoogle Scholar
  2. Bowman WC, Goldberg AAJ, Raper C (1962) A comparison between the effects of a tetanus and the effects of sympathomimetic amines on the fast- and slow-contracting mammalian muscles. Br J Pharmacol 19:464–484Google Scholar
  3. Bülbring E, Chou TC (1947) The relative activity of prostigmine homologues and other substances as antagonists to tubocurarine. Br J Pharmacol 2:8–22Google Scholar
  4. Chiou CY, Long JP (1969) Effects of α, α′-bis-(dimethylammoniumacetaldehyde diethylacetal)-p, p′-diacetylbiphenyl bromide (DMAE) on neuromuscular transmission. J Pharmacol Exp Ther 167:344–350PubMedGoogle Scholar
  5. Durant NN, Bowman WC, Marshall IG (1977) A comparison of the neuromuscular and autonomic blocking activities of (+)-tubocurarine and its N-methyl and O, O, N-trimethyl analogues. Eur J Pharmacol 46:297–302CrossRefPubMedGoogle Scholar
  6. Levis S, Preat S, Dauby J (1953) Étude pharmacodynamique de deux séries de curarisants de synthèse. Arch Int Pharmacodyn Ther 93:46–54Google Scholar
  7. Long JP, Evans CT, Wong S (1967) A pharmacological evaluation of hemicholinium analogs. J Pharmacol Exp Ther 155:223–230PubMedGoogle Scholar
  8. MacIntosh (1938) The effect of preganglionic section on acetylcholine in the ganglion. J Physiol 92:22PGoogle Scholar
  9. Paton WDM, Zaimis EJ (1948) Clinical potentialities of certain bisquarternary salts causing neuromuscular and ganglionic block. Nature 20:810CrossRefGoogle Scholar
  10. Paton WDM, Zaimis EJ (1951) The action of d-tubocurarine and of decamethonium on respiratory and other muscles in the cat. J Physiol 112:311–331CrossRefPubMedCentralPubMedGoogle Scholar
  11. Reitzel NL, Long JP (1959) The neuromuscular properties of α,α′-dimethylamino-4,4′-biacetophenone (hemicholinium). Arch Int Pharmacodyn Ther 119:20–30PubMedGoogle Scholar
  12. Salafsky B (1968) The effect of succinylcholine on denervated fast and slow skeletal muscle. Arch Int Pharmacodyn Ther 174:294–303PubMedGoogle Scholar
  13. Wilson H, Long JP (1959) Effect of hemicholinium (HC-3) at various peripheral cholinergic transmitting sites. Arch Int Pharmacodyn Ther 120:343–352PubMedGoogle Scholar

Evaluation of Neuromuscular Blockade in Cats, Pigs, Dogs and Monkeys

  1. Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar I (1988) Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 69:57–62CrossRefPubMedGoogle Scholar
  2. Brown KM, Dennis JS (1972) Derivative free analogs of the Levenberg-Marquardt and Gauss algorithms for non-linear least square approximation. Numer Math 18:288–297Google Scholar
  3. Clutton RE, Boyd C, Flora R, Payne J, McGrath CJ (1992) Autonomic and cardiovascular effects of neuromuscular blockade antagonism in the dog. Vet Surg 21:68–75CrossRefPubMedGoogle Scholar
  4. Cullen LK, Jones RS, Snowdon SL (1980) Neuromuscular activity in the intact dog: techniques for recording evoked mechanical responses. Br Vet J 136:154–159Google Scholar
  5. Hoppe JO (1950) A pharmacological investigation of 2,5-bis-(3-diethylaminopropylamino)benzoquinone-bis-benzylchloride (WIN 2747) A new curarimimetic drug. J Pharmacol Exp Ther 100:333–345PubMedGoogle Scholar
  6. Hughes R (1984) Experimental and clinical evaluation of neuromuscular blocking agents. J Pharmacol Meth 12:1–27CrossRefGoogle Scholar
  7. Hughes R, Chapple DJ (1976a) Effects of non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br J Anaesth 48:59–68CrossRefPubMedGoogle Scholar
  8. Hughes R, Chapple DJ (1976b) Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys. Br J Anaesth 48:847–852CrossRefPubMedGoogle Scholar
  9. Hughes R, Chapple DJ (1981) The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Pharmacol 53:31–44Google Scholar
  10. Keesey JC (1988) AAEE minimonograph33: electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 12:613–626CrossRefGoogle Scholar
  11. Khuenl-Brady K, Castagnoli KP, Canfell PC, Caldwell JE, Agoston S, Miller RD (1990) The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat. Anesthesiology 72:669–674CrossRefPubMedGoogle Scholar
  12. Marshall RJ, Muir AW, Sleigh T, Savage DS (1994) An overview of the pharmacology of rocuronmium bromide in experimental animals. Eur J Anaesthesiol 11(Suppl 9):9–15Google Scholar
  13. Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG (1989) Effects of a new neuromuscular blocking agent (ORG 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 63:400–410Google Scholar
  14. Muir AW, Anderson K, Marshall RJ, Booij LHDJ, Crul FJ, Prior C, Bowman WC, Marshall IG (1991) The effects of a 16-N-homopyridine analogue of vecuronium in anesthetized cats, pigs, dogs and monkeys, and in isolated preparations. Acta Anaesthesiol Scand 35:85–90CrossRefPubMedGoogle Scholar
  15. Ono H, Saito KI, Kondo M, Morishita SI, Kato K, Hasebe Y, Nakayama M, Kato F, Nakamura T, Satoh M, Oka JI, Goto M, Fukuda H (1990) Effects of the new centrally acting muscle relaxant 7-chloro-N,N,3-trimethylbenzo[b]furan-2-carboxamide on motor and central nervous systems in rats. Arzneimittelforschung 40:730–735PubMedGoogle Scholar
  16. Paton WDM (1957) Histamine release by compounds of simple chemical structure. Pharmacol Rev 9:269–328PubMedGoogle Scholar
  17. Savarese JJ (1979) The autonomic margins of safety of metocurine and d-tubocurarine in the cat. Anesthesiology 50:40–46CrossRefPubMedGoogle Scholar
  18. Walts LF (1973) The “Boomerang” – a method for recording adductor pollicis tension. Can Anaesth Soc J 20:706–708CrossRefPubMedGoogle Scholar

Evaluation of Neuromuscular Blockade in Anesthetized Mice

  1. Cullen LK, Jones RS, Snowdon SL (1980) Neuromuscular activity in the intact dog: techniques for recording evoked mechanical responses. Br Vet J 136:154–159Google Scholar
  2. Keesey JC (1989) AAEE Minimonograph 33: electrodiagnosis approach to defects of neuromuscular transmission. Muscle Nerve 12:613–626CrossRefPubMedGoogle Scholar
  3. Lefebvre HP, Cardona A, Toutain PL, Morel E, Bach JF, Vernetder-Garabedian B (1992) A simple method for the quantitative evaluation of neuromuscular blockade in mice. J Pharmacol Toxicol Methods 27:129–133CrossRefPubMedGoogle Scholar

Safety Pharmacology

  1. Vogel HG (2006) Chapter I.H. Peripheral nervous system. In: Vogel HG, Hock FJ, Maas J, Mayer D (eds) Drug discovery and evaluation safety and pharmacokinetic assays. Springer, Berlin/Heidelberg/New York, pp 195–209CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Neurologische KlinikHeinrich-Heine UniversitätDüsseldorfGermany

Personalised recommendations